Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 985 products on this category.

Product data	Purity	Price range	Estimated delivery
Abiraterone Impurity 4 REF: 4Z-A-8237CAS: 2118-32-3	- - -	To inquire	Mon 23 Dec 24
(E/Z)Tamoxifen REF: 4Z-T-0121CAS: 7728-73-6	- - -	To inquire	Mon 23 Dec 24
Carfilzomib Impurity 24 REF: 4Z-C-121027CAS: 2049025-49-0	- - -	To inquire	Mon 23 Dec 24
Carfilzomib Impurity 57 REF: 4Z-C-121060CAS: 254888-42-1	- - -	To inquire	Mon 23 Dec 24
Olaparib Impurity 10 DiHCl REF: 4Z-O-032012CAS: 142-64-3	- - -	To inquire	Mon 23 Dec 24
Nintedanib Impurity 100 REF: 4Z-N-066114	- - -	To inquire	Mon 23 Dec 24
Carfilzomib Impurity 46 REF: 4Z-C-121049	- - -	To inquire	Mon 23 Dec 24
Carfilzomib Impurity 58 REF: 4Z-C-121061CAS: 1541171-68-9	- - -	To inquire	Mon 23 Dec 24
Nintedanib Impurity 97 REF: 4Z-N-066110CAS: 2097505-01-4	- - -	To inquire	Mon 23 Dec 24
O-Chlorobutylabiraterone REF: 4Z-A-8224	- - -	To inquire	Mon 23 Dec 24
Nintedanib-O-Methyl-13C-d3 (Intedanib-O-Methyl-13C-d3) REF: 4Z-N-066021	- - -	To inquire	Mon 23 Dec 24
Palbociclib Impurity 39 REF: 4Z-P-196046CAS: 571189-65-6	- - -	To inquire	Mon 23 Dec 24
Olaparib Impurity 37 REF: 4Z-O-032042	- - -	To inquire	Mon 23 Dec 24
Tamoxifen EP Impurity H REF: 4Z-T-0119CAS: 809285-09-4	- - -	To inquire	Mon 23 Dec 24
Abiratetone-d4 Succinate REF: 4Z-A-8233	- - -	To inquire	Mon 23 Dec 24
Nintedanib Impurity 72 (Intedanib Impurity 72) REF: 4Z-N-066006CAS: 1610881-60-1	- - -	To inquire	Mon 23 Dec 24
Olaparib Impurity 44 REF: 4Z-O-032049	- - -	To inquire	Mon 23 Dec 24
Nintedanib Impurity 52 REF: 4Z-N-066070CAS: 1373232-85-9	- - -	To inquire	Mon 23 Dec 24
Palbociclib Impurity 66 REF: 4Z-P-196073	- - -	To inquire	Mon 23 Dec 24
Olaparib Impurity 70 REF: 4Z-O-032075CAS: 1937362-45-2	- - -	To inquire	Mon 23 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Abiraterone Impurity 4

Ref: 4Z-A-8237

(E/Z)Tamoxifen

Ref: 4Z-T-0121

Carfilzomib Impurity 24

Ref: 4Z-C-121027

Carfilzomib Impurity 57

Ref: 4Z-C-121060

Olaparib Impurity 10 DiHCl

Ref: 4Z-O-032012

Nintedanib Impurity 100

Ref: 4Z-N-066114

Carfilzomib Impurity 46

Ref: 4Z-C-121049

Carfilzomib Impurity 58

Ref: 4Z-C-121061

Nintedanib Impurity 97

Ref: 4Z-N-066110

O-Chlorobutylabiraterone

Ref: 4Z-A-8224

Nintedanib-O-Methyl-13C-d3 (Intedanib-O-Methyl-13C-d3)

Ref: 4Z-N-066021

Palbociclib Impurity 39

Ref: 4Z-P-196046

Olaparib Impurity 37

Ref: 4Z-O-032042

Tamoxifen EP Impurity H

Ref: 4Z-T-0119

Abiratetone-d4 Succinate

Ref: 4Z-A-8233

Nintedanib Impurity 72 (Intedanib Impurity 72)

Ref: 4Z-N-066006

Olaparib Impurity 44

Ref: 4Z-O-032049

Nintedanib Impurity 52

Ref: 4Z-N-066070

Palbociclib Impurity 66

Ref: 4Z-P-196073

Olaparib Impurity 70

Ref: 4Z-O-032075